Transition towards the development, production and use of sustainable pharmaceuticals
This project will contribute to the EU (European Union ) strategic approach to pharmaceuticals in the environment, and to the Pharmaceutical strategy for Europe called for diversifying and secure supply chains and environmentally sustainable pharmaceuticals. The project is in the planning stage.
Funding
TransPharm has received funding from the European Union’s Horizon Europe Research and Innovation Programme under Grant Agreement No 101057816.